399 results
8-K
EX-2.2
XOMA
XOMA Corp
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:27am
CVR Payment Amount (the “CVR Payment Deduction”) and any net operating loss carryforwards or other Tax attributes (including Tax credits … ) of the Company or any Subsidiary of the Company that are available to offset such gain (and such Tax attributes shall be treated as first offsetting such gain
8-K
XOMA
XOMA Corp
3 Apr 24
Completion of Acquisition or Disposition of Assets
9:27am
applicable tax withholding. As of immediately prior to the Effective Time, each option to purchase Shares from Kinnate (“Kinnate Stock Options,” and each … and the holder of such cancelled In-the-Money Option became entitled to receive (1) an amount in cash, without interest, less any applicable tax withholding
SC TO-T/A
EX-99
KNTE
Kinnate Biopharma Inc
19 Mar 24
Third party tender offer statement (amended)
4:44pm
will be paid net of any applicable tax withholding and without interest.
The Offer is being made pursuant to the Agreement and Plan of Merger, dated … law, will be converted into the right to receive the Offer Price, without interest and subject to any applicable tax withholding. As of immediately
8-K
EX-99.1
no9gt
8 Mar 24
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
7:39am
SC TO-T
EX-99
0l2b91jkcj ya7yotv
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-T
EX-99
t6vi91wm4n
4 Mar 24
Third party tender offer statement
5:24pm
SC TO-T
EX-99
shtt 56urj2orxbn
4 Mar 24
Third party tender offer statement
5:24pm
8-K
EX-2.1
8zco9nz74b430tyrnkw
16 Feb 24
XOMA Enters into Agreement to Acquire Kinnate Biopharma
9:08am
8-K
nxi qxrgsi3f7w8rb1h
16 Feb 24
XOMA Enters into Agreement to Acquire Kinnate Biopharma
9:08am
8-K
EX-4.3
rtywvxokvhyg0b
19 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
7:40am